GlaxoSmithKline plc Asset Resilience Ratio

Latest as of September 2025: 0.02%

GlaxoSmithKline plc asset resilience ratio. GlaxoSmithKline plc (GSKN) has an Asset Resilience Ratio of 0.02% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See GSKN cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

MX$10.00 Million

≈ $575.50K USD Cash + Short-term Investments

Total Assets

MX$61.34 Billion

≈ $3.53 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of GlaxoSmithKline plc (2013–2024)

Asset resilience ratio of GlaxoSmithKline plc from 2013 to 2024. This chart shows how GlaxoSmithKline plc's Asset Resilience Ratio has changed over time. Read GSKN liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down GlaxoSmithKline plc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see GlaxoSmithKline plc balance sheet assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	MX$0.00	0%
Short-term Investments	MX$10.00 Million	0.02%
Total Liquid Assets	MX$10.00 Million	0.02%

Asset Resilience Insights

Limited Liquidity: GlaxoSmithKline plc maintains only 0.02% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

GlaxoSmithKline plc Industry Peers by Asset Resilience Ratio

Compare GlaxoSmithKline plc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Merck & Company Inc NYSE:MRK	Drug Manufacturers - General	0.22%
AstraZeneca PLC NASDAQ:AZN	Drug Manufacturers - General	0.10%
Pfizer Inc SA:PFIZ34	Drug Manufacturers - General	5.33%
Cosmo Pharmaceuticals N.V F:C43	Drug Manufacturers - General	10.92%
Zhejiang Int'L Group Co Ltd SHE:000411	Drug Manufacturers - General	0.00%
Eli Lilly and Company SA:LILY34	Drug Manufacturers - General	6.46%
Dimed S.A. Distribuidora de Medicamentos SA:PNVL3	Drug Manufacturers - General	6.34%
Zhangzhou Pientzehuang Pharmaceutical Co Ltd SHG:600436	Drug Manufacturers - General	17.40%

GlaxoSmithKline plc Asset Resilience Ratio by Year (2013–2024)

GlaxoSmithKline plc asset resilience ratio by year from 2013 to 2024. The table below shows the annual Asset Resilience Ratio data for GlaxoSmithKline plc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.04%	MX$21.00 Million ≈ $1.21 Million	MX$59.46 Billion ≈ $3.42 Billion	-3.77pp
2023-12-31	3.81%	MX$2.25 Billion ≈ $129.26 Million	MX$59.01 Billion ≈ $3.40 Billion	-3.10pp
2022-12-31	6.91%	MX$4.15 Billion ≈ $239.06 Million	MX$60.15 Billion ≈ $3.46 Billion	+6.83pp
2021-12-31	0.08%	MX$61.00 Million ≈ $3.51 Million	MX$79.10 Billion ≈ $4.55 Billion	-0.02pp
2020-12-31	0.10%	MX$78.00 Million ≈ $4.49 Million	MX$80.43 Billion ≈ $4.63 Billion	0.00pp
2019-12-31	0.10%	MX$79.00 Million ≈ $4.55 Million	MX$79.69 Billion ≈ $4.59 Billion	-0.05pp
2018-12-31	0.14%	MX$84.00 Million ≈ $4.83 Million	MX$58.07 Billion ≈ $3.34 Billion	+0.01pp
2017-12-31	0.14%	MX$78.00 Million ≈ $4.49 Million	MX$56.38 Billion ≈ $3.24 Billion	-0.01pp
2016-12-31	0.15%	MX$89.00 Million ≈ $5.12 Million	MX$59.08 Billion ≈ $3.40 Billion	+0.01pp
2015-12-31	0.14%	MX$75.00 Million ≈ $4.32 Million	MX$53.45 Billion ≈ $3.08 Billion	-0.03pp
2014-12-31	0.17%	MX$69.00 Million ≈ $3.97 Million	MX$40.65 Billion ≈ $2.34 Billion	+0.01pp
2013-12-31	0.16%	MX$66.00 Million ≈ $3.80 Million	MX$42.09 Billion ≈ $2.42 Billion	--

pp = percentage points

About GlaxoSmithKline plc

MX:GSKN Mexico Drug Manufacturers - General

Market Cap

$108.32 Billion

MX$1.88 Trillion MXN

Market Cap Rank

#229 Global

#9 in Mexico

Share Price

MX$938.00

Change (1 day)

+9.58%

52-Week Range

MX$849.00 - MX$1041.90

All Time High

MX$1096.34